COLL vs LYB · P/E 17, rev $181.9M vs P/E 21, rev $40.30B
Collegium Pharmaceutical Inc (COLL) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the COLL and LYB stock pages for the full models.
Not investment advice.